Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2025-12-25 @ 2:33 PM
Study NCT ID:
NCT07252050
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-11-26
First Post:
2025-11-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Sponsor:
University of Colorado, Denver
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-11-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-11-19
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-14
First Submit QC Date:
None
Study First Post Date:
2025-11-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-18
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED